To examine the impact of PAI-1 on the malignant phenotypes of ESCC cells, we utilized KYSE30lm3 and KYSE450lm2 (high metastatic ability) plus the corresponding KYSE30luc and KYSE450luc (low metastatic ability) cells. This evidence concerns the gene SERPINE1 and esophageal squamous cell carcinoma.